Additional file 1 of Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II
Institutions
Hebei Medical University (CN)
Central South University (CN)
University of Electronic Science and Technology of China (CN)
Tianjin Medical University Cancer Institute and Hospital (CN)
Additional file 1 of Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II
Journal
Figshare
Topics
Esophageal Cancer Research and Treatment
article
Additional file 1 of Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II
article en
Abstract
No abstract available for this paper.
Publication Tag
Figshare
Institutions
Hebei Medical University (CN), Central South University (CN), University of Electronic Science and Technology of China (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Shanxi Provincial Cancer Hospital (CN), Fourth Hospital of Hebei Medical University (CN), Henan Cancer Hospital (CN), Jiangsu Province Hospital (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Additional file 1 of Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II · Figshare (2025) | TGRS Research Map | TGRS